Kimberly C. Lin

3.4k citations

19 papers · 2.1k indexed · 1 hit paper · h-index 14

Co-authors: Kun‐Liang Guan Hyun Woo Park Steven W. Plouffe Zhipeng Meng Toshiro Moroishi Caroline M. Alexander Cun-Yu Wang Jung-Soon Mo
Topics: Hippo pathway signaling and YAP/TAZ (9 papers)Chronic Lymphocytic Leukemia Research (8 papers)Acute Myeloid Leukemia Research (6 papers)
Cited by: Cell Biology Hematology Genetics
Journals: Cell Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States China South Korea

In The Last Decade

Kimberly C. Lin

19 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alternative Wnt Signaling Activates YAP/TAZ

2015 554 citations Hyun Woo Park, Young Chul Kim et al. Cell profile →

Peers

Countries citing papers authored by Kimberly C. Lin

Since Specialization

Citations

This map shows the geographic impact of Kimberly C. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly C. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly C. Lin more than expected).

Fields of papers citing papers by Kimberly C. Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly C. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly C. Lin. The network helps show where Kimberly C. Lin may publish in the future.

Co-authorship network of co-authors of Kimberly C. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly C. Lin. A scholar is included among the top collaborators of Kimberly C. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly C. Lin. Kimberly C. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	The Hippo pathway mediates Semaphorin signaling 2022 ·Science Advances ·Zhipeng Meng,(unknown),Cao Fang,(unknown),Yunjiang Qiu,Ying Wang,Xiaomin Cai,Kimberly C. Lin,Di Yang,Min Luo,Vivian Fu,Xiaoxiao Ma,Yarui Diao,Filippo G. Giancotti,Bing Ren,Adam J. Engler,Kun‐Liang Guan	12
2	Publisher Correction: Heat stress activates YAP/TAZ to induce the heat shock transcriptome 2020 ·Nature Cell Biology ·Min Luo,Zhipeng Meng,Toshiro Moroishi,Kimberly C. Lin,Guobo Shen,Fei Mo,Bin Shao,Xiawei Wei,Ping Zhang,Yuquan Wei,Kun‐Liang Guan	2
3	Heat stress activates YAP/TAZ to induce the heat shock transcriptome 2020 ·Nature Cell Biology ·Min Luo,Zhipeng Meng,Toshiro Moroishi,Kimberly C. Lin,Guobo Shen,Fei Mo,Bin Shao,Xiawei Wei,Ping Zhang,Yuquan Wei,Kun‐Liang Guan	69
4	Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes 2020 ·Blood Advances ·Kimberly C. Lin,Lingjun Zhang,Michael M. C. Kong,Maojing Yang,Yinghua Chen,Earl Poptic,(unknown),Jijun Xu,Connie Tam,Feng Lin	13
5	The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell 2018 ·Journal of Biological Chemistry ·Steven W. Plouffe,Kimberly C. Lin,(unknown),Frederick E. Tan,Shenghong Ma,Zhen Ye,Yunjiang Qiu,Bing Ren,Kun‐Liang Guan	174
6	Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis 2017 ·Blood ·Catherine C. Smith,Amy L. Paguirigan,Grace R. Jeschke,Kimberly C. Lin,Evan Massi,(unknown),Chen-Shan Chin,Saurabh Asthana,Adam B. Olshen,Kevin Travers,Susana Wang,Mark J. Levis,Alexander E. Perl,Jerald P. Radich,Neil P. Shah	120
7	A tiling-deletion-based genetic screen for cis-regulatory element identification in mammalian cells 2017 ·Nature Methods ·Yarui Diao,Rongxin Fang,Bin Li,Zhipeng Meng,Juntao Yu,Yunjiang Qiu,Kimberly C. Lin,Hui Huang,Tristin Liu,Ryan J. Marina,Inkyung Jung,Yin Shen,Kun‐Liang Guan,Bing Ren	169
8	Regulation of the Hippo Pathway Transcription Factor TEAD 2017 ·Trends in Biochemical Sciences ·Kimberly C. Lin,Hyun Woo Park,Kun‐Liang Guan	229
9	Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation 2017 ·Nature Cell Biology ·Kimberly C. Lin,Toshiro Moroishi,Zhipeng Meng,Han-Sol Jeong,Steven W. Plouffe,Yoshitaka Sekido,Jiahuai Han,Hyun Woo Park,Kun‐Liang Guan	156
10	Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer 2017 ·Kimberly C. Lin,Hyun Woo Park,Kun‐Liang Guan	15
11	Characterization of Hippo Pathway Components by Gene Inactivation 2016 ·Molecular Cell ·Steven W. Plouffe,Zhipeng Meng,Kimberly C. Lin,Brian Lin,Audrey W. Hong,(unknown),Kun‐Liang Guan	212
12	Alternative Wnt Signaling Activates YAP/TAZbreakdown → 2015 ·Cell ·Hyun Woo Park,Young Chul Kim,Bo Yu,Toshiro Moroishi,Jung-Soon Mo,Steven W. Plouffe,Zhipeng Meng,Kimberly C. Lin,Fa‐Xing Yu,Caroline M. Alexander,Cun-Yu Wang,Kun‐Liang Guan	554
13	Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy 2014 ·eLife ·(unknown),Michael S. Lopez,Elisabeth A. Lasater,Kimberly C. Lin,Bai‐Liang He,(unknown),Catherine C. Smith,Neil P. Shah,Kevan M. Shokat	44
14	Crenolanib is a selective type I pan-FLT3 inhibitor 2014 ·Proceedings of the National Academy of Sciences ·Catherine C. Smith,Elisabeth A. Lasater,Kimberly C. Lin,Qi Wang,Melissa Q. McCreery,(unknown),Lauren E. Damon,Alexander E. Perl,Grace R. Jeschke,Mayumi Sugita,Martin Carroll,Scott C. Kogan,John Kuriyan,Neil P. Shah	172
15	Preclinical and Clinical Resistance Mechanisms To The Investigational Selective FLT3 Inhibitor PLX3397 In FLT3-ITD+ Acute Myeloid Leukemia (AML) 2013 ·Blood ·Catherine C. Smith,Kimberly C. Lin,Elisabeth A. Lasater,(unknown),Lauren E. Damon,Andrew Kasarskis,Ali Bashir,Matthew Pendleton,Robert Sebra,Alexander E. Perl,Mai H. Le,Chao Zhang,Brian L. West,Neil P. Shah	6
16	Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD 2013 ·Blood ·Catherine C. Smith,Elisabeth A. Lasater,Xiaotian Zhu,Kimberly C. Lin,(unknown),Lauren E. Damon,Sara Salerno,Neil P. Shah	101
17	Constitutively Activating Mutations At the FLT3 Activation Loop Residue D835 Are Associated with Clinical Resistance to AC220 2012 ·Blood ·Catherine C. Smith,(unknown),Elisabeth A. Lasater,Amy L. Paguirigan,Kimberly C. Lin,(unknown),Sara Salerno,Lauren E. Damon,Mark J. Levis,Alexander E. Perl,Kevin Travers,Andrew Kasarskis,Jerald P. Radich,Neil P. Shah	4
18	Crenolanib (CP-868,596) Is a Potent and Selective Type I FLT3 Inhibitor That Retains Activity Against AC220 Resistance-Causing FLT3 Kinase Domain Mutants 2012 ·Blood ·Catherine C. Smith,Elisabeth A. Lasater,Melissa Q. McCreery,Kimberly C. Lin,(unknown),Lauren E. Damon,Alexander E. Perl,Grace R. Jeschke,Mayumi Sugita,Martin Carroll,Scott C. Kogan,Neil P. Shah	14
19	Single Molecule Real Time (SMRT™) Sequencing Sensitively Detects the Evolution of Polyclonal and Compound BCR-ABL Mutations in Patients Who Relapse On Kinase Inhibitor Therapy 2012 ·Blood ·Catherine C. Smith,Michael P. Brown,Wendy T Parker,Kimberly C. Lin,Kevin Travers,Susana Wang,Susan Branford,Neil P. Shah	3

About Kimberly C. Lin

Kimberly C. Lin is a scholar working on Genetics, Hematology and Cell Biology, having authored 19 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Cell Biology (1.0k citations), Hematology (407 citations) and Genetics (200 citations). Kimberly C. Lin has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Kun‐Liang Guan, Hyun Woo Park, Steven W. Plouffe, Zhipeng Meng, Toshiro Moroishi, Caroline M. Alexander, Cun-Yu Wang, Jung-Soon Mo, Fa‐Xing Yu and Young Chul Kim. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact